The contribution of the nervous system in the cancer progression

키워드

참고문헌 (107)

1. Quail DF, "Microenvironmental regulation of tumor progression and metastasis", Nat Med, 19, pp.1423~1437 (2013)
2. Hanahan D, "Accessories to the crime : functions of cells recruited to the tumor microenvironment", Cancer Cell, 21, pp.309~322 (2012)
3. Huang EJ, "Neurotrophins : roles in neuronal development and function", Annu Rev Neurosci, 24, pp.677~736 (2001)
4. Aloe L, "Nerve growth factor : role in growth, differentiation and controlling cancer cell development", J Exp Clin Cancer Res, 35, pp.116~ (2016)
5. Bruno F, "Expression and signaling pathways of nerve growth factor(NGF)and pro-NGF in breast cancer : a systematic review", Curr Oncol, 29, pp.8103~8120 (2022)
6. Wu R, "Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells", Oncogene, 40, pp.2165~2181 (2021)
7. Nakagawara A, "Expression and function of TRK-B and BDNF in human neuroblastomas", Mol Cell Biol, 14, pp.759~767 (1994)
8. Roesler R, "BDNF", TrkB signaling as an antiumor target, 2011, pp.11, 1473~1475
9. Thiele CJ, "On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology", Clin Cancer Res, 15, pp.5962~5967 (2009)
10. Radin DP, "BDNF : an oncogene or tumor suppressor?", Anticancer Res, 37, pp.3983~3990 (2017)
11. Meng L, "Targeting the BDNF", TrkB pathway for the treatment of tumors, 2019, pp.17, 2031~2039
12. Wiesenhofer B, "Glial cell line-derived neurotrophic factor(GDNF)and its receptor(GFR-alpha 1)are strongly expressed in human gliomas", Acta Neuropathol, 99, pp.131~137 (2000)
13. Cao H, "The role of Glial cell derived neurotrophic factor in head and neck cancer", PLoS One, 15, pp.e0229311~ (2020)
14. Zeng J, "CancerSCEM : a database of single-cell expression map across various human cancers", Nucleic Acids Res, 50, pp.D1147~D1155 (2022)
15. Bruno F, "The nerve growth factor receptor(NGFR", p75(NTR)) : a major player in alzheimer’s disease, 2023, pp.24, 3200~
16. Peng T, "Nerve growth factor(NGF)encourages the neuroinvasive potential of pancreatic cancer cells by activating the warburg effect and promoting tumor derived exosomal miRNA-21 expression", Oxid Med Cell Longev, 2022, pp.8445093~ (2022)
17. Campos X, "Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer", Gynecol Oncol, 104, pp.168~175 (2007)
18. Tapia V, "Tyrosine kinase A receptor(trkA) : a potential marker in epithelial ovarian cancer", Gynecol Oncol, 121, pp.13~23 (2011)
19. Pundavela J, "Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer", Mol Oncol, 9, pp.1626~1635 (2015)
20. Dollé L, "Nerve growth factor overexpression and autocrine loop in breast cancer cells", Oncogene, 22, pp.5592~5601 (2003)
21. Lei Y, "Gold nanoclustersassisted delivery of NGF siRNA for effective treatment of pancreatic cancer", Nat Commun, 8, pp.15130~ (2017)
22. Patani N, "Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer", Cancer Cell Int, 11, pp.23~ (2011)
23. Wójtowicz K, "Brain-derived neurotrophic factor(bdnf)concentration levels in cerebrospinal fluid and plasma in patients with glioblastoma : a prospective, observational, controlled study", Cureus, 15, pp.e48237~ (2023)
24. Tian GA, "BDNF expression in GISTs predicts poor prognosis when associated with PD-L1positive tumor-infiltrating lymphocytes", Oncoimmunology, 10, pp.2003956~ (2021)
25. Allen JK, "Sustained adrenergic signaling promotes intratumoral innervation through BDNF induction", Cancer Res, 78, pp.3233~3242 (2018)
26. Lange AM, "Inhibiting TRK Proteins in Clinical Cancer Therapy", Cancers(Basel), 10, pp.105~ (2018)
27. Lin LF, "GDNF : a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons", Science, 260, pp.1130~1132 (1993)
28. Ceyhan GO, "Neural invasion in pancreatic cancer : a mutual tropism between neurons and cancer cells", Biochem Biophys Res Commun, 374, pp.442~447 (2008)
29. Cavel O, "Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor", Cancer Res, 72, pp.5733~5743 (2012)
30. Song H, "Glial cell-derived neurotrophic factor(GDNF)promotes low-grade Hs683 glioma cell migration through JNK, ERK-1", 2 and p38 MAPK signaling pathways, 2006, pp.56, 29~38
31. Lu DY, "Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells", Biochem Pharmacol, 80, pp.1201~1209 (2010)
32. Ban K, "RET signaling in prostate cancer", Clin Cancer Res, 23, pp.4885~4896 (2017)
33. Baspinar S, "Expression of NGF, GDNF and MMP-9 in prostate carcinoma", Pathol Res Pract, 213, pp.483~489 (2017)
34. Basu AK, "DNA damage, mutagenesis and cancer", Int J Mol Sci, 19, pp.970~ (2018)
35. Huber RM, "DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance", Oncotarget, 6, pp.2134~2147 (2015)
36. Liu D, "Characterization of ontarget adverse events caused by TRK inhibitor therapy", Ann Oncol, 31, pp.1207~1215 (2020)
37. Frisbie JH, "Low prevalence of prostatic cancer among myelopathy patients", J Am Paraplegia Soc, 17, pp.148~149 (1994)
38. Rutledge A, "Spinal cord injuries and nerve dependence in prostate cancer", Trends in Cancer, 3, pp.812~815 (2017)
39. Gholizadeh N, "Characterization of prostate cancer using diffusion tensor imaging : a new perspective", Eur J Radiol, 110, pp.112~120 (2019)
40. Grytli HH, "Association between use of β-blockers and prostate cancer-specific survival : a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease", Eur Urol, 65, pp.635~641 (2014)
41. Waxenbaum JA, "Anatomy, autonomic nervous system" (2023), StatPearls
42. LeBouef T, "Physiology, autonomic nervous system" (2023), StatPearls
43. Magnon C, "Autonomic nerve development contributes to prostate cancer progression", Science, 341, pp.1236361~ (2013)
44. Renz BW, "β2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer", Cancer Cell, 33, pp.75~90 (2018)
45. Barron TI, "Beta blockers and breast cancer mortality : a population-based study", J Clin Oncol, 29, pp.2635~2644 (2011)
46. Melhem-Bertrandt A, "Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer", J Clin Oncol, 29, pp.2645~2652 (2011)
47. Watkins JL, "Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer", Cancer, 121, pp.3444~3451 (2015)
48. Kamiya A, "Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression", Nat Neurosci, 22, pp.1289~1305 (2019)
49. Renz BW, "Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness", Cancer Discov, 8, pp.1458~1473 (2018)
50. Zhao CM, "Denervation suppresses gastric tumorigenesis", Sci Transl Med, 6, pp.250~ (2014)
51. Hayakawa Y, "Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling", Cancer Cell, 31, pp.21~34 (2017)
52. Peterson SC, "Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches", Cell Stem Cell, 16, pp.400~412 (2015)
53. Epstein EH, "Basal cell carcinomas : attack of the hedgehog", Nat Rev Cancer, 8, pp.743~754 (2008)
54. Xie J, "Activating Smoothened mutations in sporadic basal-cell carcinoma", Nature, 391, pp.90~92 (1998)
55. Saloman JL, "Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer", Proc Natl Acad Sci U S A, 113, pp.3078~3083 (2016)
56. Restaino AC, "Functional neuronal circuits promote disease progression in cancer", Sci Adv, 9, pp.eade4443~ (2023)
57. Pan S, "Stimulation of hypothalamic oxytocin neurons suppresses colorectal cancer progression in mice", Elife, 10, pp.e67535~ (2021)
58. Xiong SY, "A brain-tumor neural circuit controls breast cancer progression in mice", J Clin Invest, 133, pp.e167725~ (2023)
59. Smith GW, "Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development", Neuron, 20, pp.1093~1102 (1998)
60. Yan J, "Chronic stress in solid tumor development : from mechanisms to interventions", J Biomed Sci, 30, pp.8~ (2023)
61. Aggarwal BB, "Targeting inflammatory pathways for prevention and therapy of cancer : short-term friend, long-term foe", Clin Cancer Res, 15, pp.425~430 (2009)
62. Grivennikov SI, "Immunity, inflammation, and cancer", Cell, 140, pp.883~899 (2010)
63. Okusa MD, "Targeting neural reflex circuits in immunity to treat kidney disease", Nat Rev Nephrol, 13, pp.669~680 (2017)
64. Mueller SN, "Neural control of immune cell trafficking", J Exp Med, 219, pp.e20211604~ (2022)
65. Pavlov VA, "Neural regulation of immunity : molecular mechanisms and clinical translation", Nat Neurosci, 20, pp.156~166 (2017)
66. Rosas-Ballina M, "Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit", Science, 334, pp.98~101 (2011)
67. Guarini S, "Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock", Circulation, 107, pp.1189~1194 (2003)
68. de Jonge WJ, "Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway", Nat Immunol, 6, pp.844~851 (2005)
69. Wang H, "Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation", Nature, 421, pp.384~388 (2003)
70. Pavlov VA, "The vagus nerve and the inflammatory reflex--linking immunity and metabolism", Nat Rev Endocrinol, 8, pp.743~754 (2012)
71. Yang MW, "Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma", Cancer Res, 80, pp.1991~2003 (2020)
72. Partecke LI, "Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model", Oncotarget, 8, pp.22501~22512 (2017)
73. Montfort A, "The TNF paradox in cancer progression and immunotherapy", Front Immunol, 10, pp.1818~ (2019)
74. Lugano R, "Tumor angiogenesis : causes, consequences, challenges and opportunities", Cell Mol Life Sci, 77, pp.1745~1770 (2020)
75. Eichmann A, "Molecular parallels between neural and vascular development", Cold Spring Harb Perspect Med, 3, pp.a006551~ (2013)
76. Romon R, "Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways", Mol Cancer, 9, pp.157~ (2010)
77. Lin CY, "Brain-derived neurotrophic factor promotes VEGF-C-dependent lymphangiogenesis by suppressing miR-624-3p in human chondrosarcoma cells", Cell Death Dis, 8, pp.e2964~ (2017)
78. Zahalka AH, "Adrenergic nerves activate an angio-metabolic switch in prostate cancer", Science, 358, pp.321~326 (2017)
79. Le CP, "Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination", Nat Commun, 7, pp.10634~ (2016)
80. Park SY, "The role of myokines in cancer : crosstalk between skeletal muscle and tumor", BMB Rep, 56, pp.365~373 (2023)
81. Jeong SM, "The impact of cancer cachexia on gut microbiota composition and short-chain fatty acid metabolism in a murine model", BMB Rep, 56, pp.404~409 (2023)
82. Fearon K, "Definition and classification of cancer cachexia : an international consensus", Lancet Oncol, 12, pp.489~495 (2011)
83. Deboer MD, "Cachexia : lessons from melanocortin antagonism", Trends Endocrinol Metab, 17, pp.199~204 (2006)
84. Yang L, "GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand", Nat Med, 23, pp.1158~1166 (2017)
85. Zahalka AH, "Adrenergic nerves activate an angio-metabolic switch in prostate cancer", Science, 358, pp.321~326 (2017)
86. Lerner L, "Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients", J Cachexia Sarcopenia Muscle, 6, pp.317~324 (2015)
87. Staff AC, "Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer", Gynecol Oncol, 118, pp.237~243 (2010)
88. Li C, "Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer", J Cell Mol Med, 20, pp.1420~1426 (2016)
89. Tsai VWW, "The MIC-1", GDF15-GFRAL pathway in energy homeostasis : implications for obesity, cachexia, and other associated diseases, 2018, pp.28, 353~368
90. Lerner L, "MAP3K11", GDF15 axis is a critical driver of cancer cachexia, 2016, pp.7, 467~482
91. Wischhusen J, "Growth", differentiation factor-15(GDF-15) : from biomarker to novel targetable immune checkpoint, 2020, pp.11, 951~
92. Tsai VW, "TGF-b superfamily cytokine MIC-1", GDF15 is a physiological appetite and body weight regulator, 2013, pp.8, e55174~
93. Hsu JY, "Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15", Nature, 550, pp.255~259 (2017)
94. Wang D, "GDF15 promotes weight loss by enhancing energy expenditure in muscle", Nature, 619, pp.143~150 (2023)
95. Sjøberg KA, "GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism", Cell Metab, 35, pp.1327~1340 (2023)
96. Suriben R, "Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice", Nat Med, 26, pp.1264~1270 (2020)
97. Kim-Muller JY, "GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia", Cell Rep, 42, pp.111947~ (2023)
98. Kang GM, "Mitohormesis in hypothalamic POMC neurons mediates regular exerciseinduced high-turnover metabolism", Cell Metab, 33, pp.334~349 (2021)
99. Plum L, "Enhanced PIP3signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity", J Clin Invest, 116, pp.1886~1901 (2006)
100. Xu W, "Activation of POMC neurons to adiponectin participating in EA-mediated improvement of high-fat diet IR mice", Front Neurosci, 17, pp.1145079~ (2023)
101. McMinn JE, "Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression", Am J Physiol Regul Integr Comp Physiol, 279, pp.R695~R703 (2000)
102. Zhu X, "Melanocortin-4 receptor antagonist TCMCB07ameliorates cancer-and chronic kidney disease-associated cachexia", J Clin Invest, 130, pp.4921~4934 (2020)
103. -4, 5-dihydro-1H-imidazole(ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model, "J Med Chem", 2004, 1602~1604
104. Wisse BE, "Reversal of cancer anorexia by blockade of central melanocortin receptors in rats", Endocrinology, 142, pp.3292~3301 (2001)
105. Marks DL, "Role of the central melanocortin system in cachexia", Cancer Res, 61, pp.1432~1438 (2001)
106. Duan J, "Exogenous melatonin alleviates skeletal muscle wasting by regulating hypothalamic neuropeptides expression in endotoxemia rats", Neurochem Res, 47, pp.885~896 (2022)
107. Duan K, "Hypothalamic activation is essential for endotoxemia-induced acute muscle wasting", Sci Rep, 6, pp.38544~ (2016)

관련 논문AI추천